Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-1-11
pubmed:abstractText
It has been established that periodontal diseases are more prevalent and of greater severity in diabetic patients than in nondiabetic patients. Recent studies have underscored the role of monocytes and macrophages in periodontal tissue inflammation and destruction in diabetic patients. Although it has been shown that monocytes isolated from diabetic patients produce more inflammatory cytokines and that gingival crevicular fluid collected from diabetic patients contains higher levels of inflammatory cytokines than that obtained from nondiabetic patients, the underlying mechanisms are not well understood.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
D
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/Fenofibrate, http://linkedlifedata.com/resource/pubmed/chemical/Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Inflammation Mediators, http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type II, http://linkedlifedata.com/resource/pubmed/chemical/Peroxisome Proliferator-Activated..., http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin, http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones, http://linkedlifedata.com/resource/pubmed/chemical/pioglitazone
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-3484
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
31-8
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17214637-Chemokines, pubmed-meshheading:17214637-Cytokines, pubmed-meshheading:17214637-Fenofibrate, pubmed-meshheading:17214637-Glucose, pubmed-meshheading:17214637-Histiocytes, pubmed-meshheading:17214637-Humans, pubmed-meshheading:17214637-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:17214637-Hypoglycemic Agents, pubmed-meshheading:17214637-Hypolipidemic Agents, pubmed-meshheading:17214637-Inflammation Mediators, pubmed-meshheading:17214637-Lipopolysaccharides, pubmed-meshheading:17214637-Nitric Oxide, pubmed-meshheading:17214637-Nitric Oxide Synthase Type II, pubmed-meshheading:17214637-Peroxisome Proliferator-Activated Receptors, pubmed-meshheading:17214637-Simvastatin, pubmed-meshheading:17214637-Thiazolidinediones, pubmed-meshheading:17214637-Time Factors, pubmed-meshheading:17214637-U937 Cells
pubmed:year
2007
pubmed:articleTitle
High glucose-boosted inflammatory responses to lipopolysaccharide are suppressed by statin.
pubmed:affiliation
Division of Endocrinology, Diabetes and Medical Genetics, Department of Medicine, Medical University of South Carolina, Charleston, SC 29403, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural